Cargando…
SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
BACKGROUND: At the beginning of the pandemic, there have been considerable concerns regarding coronavirus disease 2019 (COVID-19) severity and outcomes in patients with severe asthma treated with biologics. OBJECTIVE: To prospectively observe a cohort of severe asthmatics treated with biologics for...
Ejemplares similares
-
Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
por: Bartziokas, Konstantinos, et al.
Publicado: (2023) -
IL-26 in the Lung and Its Role in COPD Inflammation
por: Bartziokas, Konstantinos, et al.
Publicado: (2022) -
Primary care and COVID-19: cutting the Gordian knot – the Greek experience and algorithm
por: Tomos, Ioannis, et al.
Publicado: (2020) -
Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
por: Papaporfyriou, Anastasia, et al.
Publicado: (2023) -
Predictors of Mortality in Tocilizumab-Treated Severe COVID-19
por: Pagkratis, Konstantinos, et al.
Publicado: (2022)